Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

Nytt program ska hjälpa akademisk forskning till marknaden

Steget från akademisk forskning till kommersialisering inom life science är ofta tufft. Nu lanseras ett nytt finanseringsprogram för att överbrygga gapet.

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by an extensive Scandinavian study....

Galenica AB

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Efficient use of blood plasma

Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...

Olink inleder strategiskt samarbete med Tataa

Olink, som utvecklar avancerade lösningar inom proteinanalys, inleder ett strategiskt samarbete med det snabbväxande labbföretaget Tataa Biocenter och lanserar ...

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

Explore the latest trends and innovations in quality assurance and manufacturing

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Medicon Valley Alliance

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

Aegirbios köpplaner spricker efter börsras

Aegirbios planer på att förvärva testbolaget Dynamic Code spricker. Som orsak anges den negativa börsutvecklingen i Aegirbio.

Dynamic code valde crowdfunding

I det nya vårdlandskapet är det inte bara patienter som använder sig av crowdfunding. Även bolag kan använda metoden för att dra in kapital.

Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas

Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Improved processes and more

Discover the full potential and benefits.

Nivågivare med Bluetooth för smidig och enkel kommunikation

Nivågivare FLR från Kuebler erbjuder kontinuerlig nivåmätning som bygger på flottörprincipen. Med Bluetooth slipper du kabeldragning och får en smidig och enkel...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Small robots to deliver pharmaceuticals to the body

Robots that can operate inside the body and a platform that combines ultrasound with AI. These are a couple of the technologies that have qualified for a list t...